Variant report
Variant | nsv564889 |
---|---|
Chromosome Location | chr14:62705334-62755733 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113635466 | chr14:62713634-62713635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs182140664 | chr14:62713658-62713659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368696978 | chr14:62713710-62713711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148467883 | chr14:62713734-62713735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186738538 | chr14:62713743-62713744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552057918 | chr14:62713744-62713745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs190055773 | chr14:62713758-62713759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs375328282 | chr14:62713784-62713785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528368805 | chr14:62713819-62713820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541805716 | chr14:62713843-62713844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555233270 | chr14:62713858-62713859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs567945258 | chr14:62713877-62713878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182162918 | chr14:62713921-62713922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs368201274 | chr14:62713929-62713930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs142612424 | chr14:62713969-62713970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs78963685 | chr14:62714005-62714006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs79589992 | chr14:62714029-62714030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186123682 | chr14:62714048-62714049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189804898 | chr14:62714062-62714063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs77322011 | chr14:62714100-62714101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535753584 | chr14:62714122-62714123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376614346 | chr14:62714145-62714146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536461798 | chr14:62714147-62714148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555765821 | chr14:62714148-62714149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs575517244 | chr14:62714149-62714150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs555947645 | chr14:62714151-62714152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs544323585 | chr14:62714160-62714161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557785983 | chr14:62714189-62714190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs77490653 | chr14:62714198-62714199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375959222 | chr14:62714226-62714227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs563307623 | chr14:62714270-62714271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs140614856 | chr14:62714274-62714275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545637405 | chr14:62714367-62714368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144485918 | chr14:62714428-62714429 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145696303 | chr14:62714437-62714438 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs140075731 | chr14:62714463-62714464 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10133065 | chr14:62714476-62714477 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs182130371 | chr14:62714542-62714543 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185615209 | chr14:62714558-62714559 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191152292 | chr14:62714567-62714568 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570601453 | chr14:62714593-62714594 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533056681 | chr14:62714605-62714606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs11622179 | chr14:62714607-62714608 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs116472251 | chr14:62714657-62714658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1399524 | chr14:62714658-62714659 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs183857517 | chr14:62714685-62714686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555757815 | chr14:62714704-62714705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs78756810 | chr14:62714709-62714710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537808804 | chr14:62714710-62714711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs11845584 | chr14:62714733-62714734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Breast cancer | 22032731 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 17603634 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Leukemia | 18688285 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Intellectual disability | 21811512 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:62713600-62714400 | Enhancers | Fetal Lung | lung |
2 | chr14:62714200-62714600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
3 | chr14:62714400-62717800 | Weak transcription | Fetal Lung | lung |
4 | chr14:62716000-62716400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr14:62716400-62717400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr14:62717400-62719000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr14:62717600-62718800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr14:62717800-62718400 | Enhancers | HepG2 | liver |
9 | chr14:62717800-62719000 | Enhancers | Stomach Mucosa | stomach |
10 | chr14:62717800-62720600 | Enhancers | Fetal Lung | lung |
11 | chr14:62719000-62719400 | Weak transcription | Stomach Mucosa | stomach |
12 | chr14:62719200-62719600 | Enhancers | Fetal Stomach | stomach |
13 | chr14:62719400-62721400 | Enhancers | Stomach Mucosa | stomach |
14 | chr14:62719600-62720600 | Weak transcription | Fetal Stomach | stomach |
15 | chr14:62720600-62720800 | Enhancers | Fetal Stomach | stomach |
16 | chr14:62724800-62725400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
17 | chr14:62746200-62746600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
18 | chr14:62747400-62747800 | Enhancers | Cortex derived primary cultured neurospheres | brain |